1 Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 2 Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 3 Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 4 Center for Cardiovascular Prevention of the First Faculty of Medicine Charles University and Thomayer Hospital, Prague, Czech Republic. 5 International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. 6 Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 7 Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 8 Address correspondence to: Peter Balaz, M.D., Ph.D., Department of Transplant Surgery, Transplantcenter, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 14821 Prague, Czech Republic.
Transplantation. 2013 Oct 15;96(7):633-8. doi: 10.1097/TP.0b013e31829d9225.
Organ shortage leads to the increased use of expanded-criteria donor (ECD) kidneys, which contribute to a higher risk of delayed graft function (DGF) after transplantation. The aim of this study was to determine factors that may better predict the risk of DGF.
Histologic assessments of donor renal biopsy were used with other clinical variables to predict the risk of DGF after kidney transplantation. The total Banff score equaled the sum of interstitial fibrosis (CI), tubular atrophy, arteriolar hyaline thickening, fibrous intimal thickening (CV), and fraction of sclerotized glomeruli.
In total, 126 of 344 patients developed DGF after kidney transplantation. The histologic score for CI, tubular atrophy, and CV and the total Banff score were increased in patients with DGF. Only CI and CV were independent predictors of DGF (P<0.01). A CIV score (CI+CV; odds ratio, 2.68; 95% confidence interval, 1.55-4.66; P<0.001) was superior to the combination of the total Banff score (odds ratio, 1.48; 95% confidence interval, 0.85-2.55; P=NS). A CIV score≥1, donor age more than 51 years, and anoxia donor brain injury were associated with the highest risk of DGF. A CIV<1 identified a subgroup of ECDs at a lower risk of DGF comparable with standard-criteria donors (29.3% vs. 28.4%).
Composite CIV score better identifies ECD kidneys with a lower risk of developing DGF. Morphologic evaluation of ECD kidneys and donor characteristics may improve kidney allocation.
器官短缺导致扩大标准供者(ECD)肾脏的使用增加,这增加了移植后延迟肾功能恢复(DGF)的风险。本研究旨在确定可能更好预测 DGF 风险的因素。
使用供体肾活检的组织学评估和其他临床变量来预测肾移植后 DGF 的风险。总 Banff 评分等于间质纤维化(CI)、肾小管萎缩、小动脉玻璃样变增厚、纤维内膜增厚(CV)和硬化肾小球分数的总和。
共有 344 例患者中的 126 例在肾移植后发生 DGF。DGF 患者的 CI、肾小管萎缩和 CV 的组织学评分以及总 Banff 评分增加。只有 CI 和 CV 是 DGF 的独立预测因素(P<0.01)。CIV 评分(CI+CV;优势比,2.68;95%置信区间,1.55-4.66;P<0.001)优于总 Banff 评分(优势比,1.48;95%置信区间,0.85-2.55;P=NS)。CIV 评分≥1、供者年龄大于 51 岁和缺氧供者脑损伤与 DGF 的最高风险相关。CIV<1 确定了一个与标准供者(29.3% vs. 28.4%)相比 DGF 风险较低的 ECD 亚组。
复合 CIV 评分可更好地识别发生 DGF 风险较低的 ECD 肾脏。ECD 肾脏和供者特征的形态学评估可能会改善肾脏分配。